Free Trial

Profound Medical (PROF) Earnings Date, Estimates & Call Transcripts

Profound Medical logo
$4.27 -0.01 (-0.23%)
As of 04:00 PM Eastern

Profound Medical Earnings Summary

Profound Medical issued Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.36, which missed analysts' consensus estimates of -$0.29 by $0.07. Quarterly revenue was reported to be $2.62 million, below the consensus estimate of $4.78 million. With a trailing EPS of -$1.22, Profound Medical's earnings are expected to grow next year, from ($1.12) to ($0.78) per share.

Latest Q1
Earnings Date
May. 8Estimated
Consensus EPS
(May. 8)
-$0.29
Actual EPS
(May. 8)
-$0.36 Missed By -$0.07
Actual Revenue
(May. 8)
$2.62M

Q1 2025 Earnings Resources

Get Profound Medical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Profound Medical and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PROF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PROF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Profound Medical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20251-$0.26-$0.26-$0.26
Q2 20251-$0.26-$0.26-$0.26
Q3 20251-$0.26-$0.26-$0.26
Q4 20251-$0.26-$0.26-$0.26
FY 2025 4 -$1.04 -$1.04 -$1.04
Q1 20261-$0.24-$0.24-$0.24
Q2 20261-$0.20-$0.20-$0.20
Q3 20261-$0.19-$0.19-$0.19
Q4 20261-$0.14-$0.14-$0.14

Profound Medical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025-$0.29-$0.36 -$0.07-$0.36$4.78M$2.62M
3/6/2025Q4 2024-$0.31-$0.20+$0.11-$0.20$5.92M$4.18M
11/7/2024Q3 2024-$0.33-$0.38 -$0.05-$0.38$3.30M$2.83M
8/8/2024Q2 2024-$0.28-$0.28--$0.28$2.50M$2.23M
5/9/2024Q1 2024-$0.31-$0.26+$0.05-$0.26$2.40M$1.91M
3/7/2024Q4 2023-$0.28-$0.42 -$0.14-$0.42$1.90M$2.01M
11/2/2023Q3 2023-$0.32-$0.26+$0.06-$0.26$2.40M$1.73M
8/9/2023Q2 2023-$0.31-$0.35 -$0.04-$0.35$2.05M$1.60M

Profound Medical Earnings - Frequently Asked Questions

Profound Medical (NASDAQ:PROF) last announced its quarterly earning data on Thursday, May 8, 2025. Learn more on PROF's earnings history.

In the previous quarter, Profound Medical (NASDAQ:PROF) missed the analysts' consensus estimate of ($0.29) by $0.07 with a reported earnings per share (EPS) of ($0.36). Learn more on analysts' earnings estimate vs. PROF's actual earnings.

The conference call for Profound Medical's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Profound Medical's latest earnings report can be read online.
Read Transcript

Profound Medical (NASDAQ:PROF) has a recorded annual revenue of $10.68 million.

Profound Medical (NASDAQ:PROF) has a recorded net income of -$28.57 million. PROF has generated -$1.22 earnings per share over the last four quarters.

Profound Medical's earnings are expected to grow from ($1.12) per share to ($0.78) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:PROF) was last updated on 5/13/2025 by MarketBeat.com Staff
From Our Partners